158 related articles for article (PubMed ID: 1658121)
1. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis.
Caporaso N; Romano M; Marmo R; de Sio I; Morisco F; Minerva A; Coltorti M
J Hepatol; 1991 May; 12(3):367-71. PubMed ID: 1658121
[TBL] [Abstract][Full Text] [Related]
2. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C antibody and cryoglobulins in patients with cirrhosis and hepatocellular carcinoma.
Rinaldi G; Saccardo F; Petrozzino MR; Bossi E; Manna MR; Monti G
Clin Exp Rheumatol; 1995; 13 Suppl 13():S161-3. PubMed ID: 8730499
[TBL] [Abstract][Full Text] [Related]
4. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
6. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study.
Goritsas CP; Athanasiadou A; Arvaniti A; Lampropoulou-Karatza C
J Clin Gastroenterol; 1995 Apr; 20(3):220-4. PubMed ID: 7797831
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
Brunetto MR; Oliveri F; Colombatto P; Bonino F
Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger.
Cenac A; Pedroso ML; Djibo A; Develoux M; Pichoud C; Lamothe F; Trepo C; Warter A
Am J Trop Med Hyg; 1995 Apr; 52(4):293-6. PubMed ID: 7537942
[TBL] [Abstract][Full Text] [Related]
9. Impact of interferon-alpha therapy on the development of hepatocellular carcinoma in patients with liver cirrhosis: results of an international survey.
Bonino F; Oliveri F; Colombatto P; Brunetto MR
J Viral Hepat; 1997; 4 Suppl 2():79-82. PubMed ID: 9429213
[TBL] [Abstract][Full Text] [Related]
10. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic.
Tsega E; Nordenfelt E; Hansson BG
Trans R Soc Trop Med Hyg; 1995; 89(2):171-4. PubMed ID: 7539952
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.
Silini E; Bottelli R; Asti M; Bruno S; Candusso ME; Brambilla S; Bono F; Iamoni G; Tinelli C; Mondelli MU; Ideo G
Gastroenterology; 1996 Jul; 111(1):199-205. PubMed ID: 8698200
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis delta virus (HDV) infection and hepatocellular carcinoma (HCC).
Oliveri F; Brunetto MR; Baldi M; Piantino P; Ponzetto A; Forzani B; Smedile A; Verme G; Bonino F
Prog Clin Biol Res; 1991; 364():217-22. PubMed ID: 1850527
[No Abstract] [Full Text] [Related]
17. Coarse nodular US pattern in hepatic cirrhosis: risk for hepatocellular carcinoma.
Caturelli E; Castellano L; Fusilli S; Palmentieri B; Niro GA; del Vecchio-Blanco C; Andriulli A; de Sio I
Radiology; 2003 Mar; 226(3):691-7. PubMed ID: 12601208
[TBL] [Abstract][Full Text] [Related]
18. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and prevention of hepatocellular carcinoma in HCV infection.
Benvegnù L; Alberti A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):49S-55S. PubMed ID: 9011476
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
